Appeals Court Backs AZ on Crestor Patent

Drug Industry Daily
A A
The Court of Appeals for the Federal Circuit has upheld a District Court finding that AstraZeneca’s ’314 composition patent on Crestor is valid.

To View This Article:

Login

Subscribe To Drug Industry Daily